Status:
TERMINATED
Trial Comparing Ketorolac Tromethamine 0.4% & Prednisolone Acetate 1% in Reducing Post-SLT Anterior Chamber Flare & Cells
Lead Sponsor:
University of Pittsburgh
Conditions:
Postoperative Complications
Inflammation
Eligibility:
All Genders
18-95 years
Brief Summary
Selective laser trabeculoplasty (SLT) is a new alternative to anti-glaucoma medications for the treatment of primary open angle glaucoma. After SLT, many patients experience mild to moderate inflammat...
Detailed Description
Selective laser trabeculoplasty (SLT) is a new alternative to anti-glaucoma medications for the treatment of primary open angle glaucoma. After SLT, many patients experience mild to moderate inflammat...
Eligibility Criteria
Inclusion
- Patients diagnosed with open angle glaucoma at the University of Pittsburgh Medical Center (UPMC) Glaucoma Clinic.
- Able to provide written informed consent to participate.
- Must be between the ages of 18 - 95.
- Patients in which further IOP lowering by SLT is necessary in the opinion of the treating physician.
Exclusion
- Patients with eye surgery in the prior six months.
- Patients with prior or current use of topical or systemic corticosteroids or NSAIDs.
- Patients with pre-existing anterior chamber inflammation.
- Patients with known sensitivity to any of the study medications.
- Due to the age range and the disease entity, special patient populations such as children or pregnant women will not be enrolled in this study.
Key Trial Info
Start Date :
February 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2007
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT00410267
Start Date
February 1 2006
End Date
December 1 2007
Last Update
August 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pittsburgh (UPMC Eye Center)
Pittsburgh, Pennsylvania, United States, 15213